Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
Kim Kardashian is profiting from her pregnancy by pushing a controversial morning sickness drug. Kardashian posted on Instagram a photo of herself with a bottle of Diclegis and a rather scripted message saying that her doctor prescribed the drug. “I’m so excited and happy with my results that I’m partnering with Duchesnay USA to raise awareness about treating morning sickness,” she writes. Diclegis is a combination of vitamin B6 and the antihistamine doxylamine. It is a delayed-release pill that is designed to be taken every day before symptoms occur. Nausea and vomiting associated with pregnancy generally occur in the morning, ... Read More
More patients than ever are being treated with blood thinners for the common irregular heart rhythm condition atrial fibrillation, thanks in part to direct-to-consumer advertising from the newest anticoagulants on the market. According to a study conducted by researchers with the University of Michigan Frankel Cardiovascular Center, doctors prescribed more than 2.83 million blood thinners in the last quarter of 2014, up about 800,000 from the start of 2009. Blood thinners are used to prevent strokes in patients with atrial fibrillation. They are also used to prevent or treat blood clots in the legs and lungs, a condition known as ... Read More
Consumer health care giant Johnson & Johnson recently reported concerning second-quarter earnings with overall sales down 8.8 percent from the same quarter last year. Some of the blame falls on the company’s medical devices division, which saw declining sales for the fourth straight quarter with not much hope for growth on the horizon, according to analysts. All three of Johnson & Johnson’s divisions – consumer products, medical devices, and pharmaceuticals – have experienced quarterly declines for the past few years. The majority of the declines were attributed to foreign exchange fluctuations, but sales in each division were weak. Declines in the company’s ... Read More
Last year, the Food and Drug Administration (FDA) ordered manufacturers of testosterone replacement products to add blood clot warnings to the safety labels of the hormones. A new study suggests testosterone supplements may not increase the risk of blood clots, but the risk for heart attacks and strokes in patients who use the therapy remains. The most common forms of blood clots in the veins, also known as venous thromboembolism (VTE), are deep vein thrombosis (blood clot in the leg) and pulmonary embolism (blood clot in the lungs). It is the third most common cardiovascular problem after heart attacks and ... Read More
A new study published in the July 21 issue of JAMA questions the link between the type 2 diabetes drug Actos and bladder cancer, but it also suggests the once-blockbuster treatment may cause pancreatic cancer. Actos, made by Takeda Pharmaceuticals, contains the active ingredient pioglitazone. In 2011, after studies showed people who took Actos were at an increased risk for bladder cancer, the Food and Drug Administration (FDA) ordered that warnings be placed on the drug’s safety label warning of bladder cancer. Takeda has since been slapped with Actos bladder cancer lawsuits, including a landmark $6 billion judgment in one ... Read More
European drug regulators have approved Amgen’s highly anticipated, first-of-a-class cholesterol-lowering drug Repatha, for patients with dangerously high cholesterol levels, including those with inherited conditions, and people who cannot tolerate statin side effects. Repatha is an injectable drug from an experimental class of drugs known as PCSK9 inhibitors. Other PCSK9 drugs are currently in development or awaiting review by drug regulators. Drugs in this class have shown in clinical trials to be superior at dramatically lowering LDL – or bad – cholesterol. Like statins, the drugs are used to prevent heart attacks and strokes in patients with high cholesterol, a risk ... Read More
A lawsuit filed by a woman who claims taking Eli Lilly & Co.’s antidepressant Prozac during pregnancy caused her child to be born with a heart defect will move forward after an Alabama federal court refused the drug company’s motion to dismiss the case. U.S. District Judge Keith Watkins found that the plaintiff, Dana Fields, had a genuine dispute against Eli Lilly, and that she could show factual causation that her doctor would not have prescribed the drug to her had he known the risks, even though the doctor is now deceased. Fields claims that in 1996 she took Prozac ... Read More
Children who take antibiotics are twice as likely to develop juvenile arthritis than children who do not take the antibacterial drugs, and the risk increases with each subsequent round of antibiotics given to a child, according to a new study. The risk was highest within a year of taking antibiotics and increased with each course children were prescribed, says lead study author, Dr. Daniel Horton, a research fellow with the Rutgers Biomedical and Health Sciences Child Health Institute of New Jersey. Researchers say the likelihood that a child will develop juvenile arthritis is rare – about one in 10,000. The ... Read More
Elderly patients with a common irregular heart rhythm known as atrial fibrillation treated with the blood thinner Xarelto are far more likely than any other age group to experience major bleeding events, according to a post-marketing study investigating the safety risks with the popular new anticoagulant. The multi-year study involved medical records of 31,883 atrial fibrillation patients ages 19 to 105 prescribed Xarelto for stroke prevention. Researchers used a validated case-finding algorithm to detect major bleeds, which matched diagnosis codes related to bleeding with patient identities. Patient demographics were identified, as was usage of other medications, treatment for bleeding, and ... Read More
A woman who filed a lawsuit against several companies after developing ovarian cancer she claims was caused by using talcum powder on her genitals for personal hygiene, has voluntarily dropped one of the defendants from her lawsuit. Judith Harlan’s lawsuit named Johnson & Johnson, Johnson & Johnson Consumer Products, Imerys Talc America, Walgreens, and the Personal Care Products Council. She filed the motion to dismiss the Council from the lawsuit in April 2015, and Circuit Judge Barbara Crowder granted the motion. Harlan claims she used Johnson’s Baby Powder from 1964 to 2013 for feminine hygiene. At age 66, she was ... Read More